A citation-based method for searching scientific literature

Chunling Hu, Steven N Hart, Eric C Polley, Rohan Gnanaolivu, Hermela Shimelis, Kun Y Lee, Jenna Lilyquist, Jie Na, Raymond Moore, Samuel O Antwi, William R Bamlet, Kari G Chaffee, John DiCarlo, Zhong Wu, Raed Samara, Pashtoon M Kasi, Robert R McWilliams, Gloria M Petersen, Fergus J Couch. JAMA 2018
Times Cited: 159

List of co-cited articles
819 articles co-cited >1

Times Cited
  Times     Co-cited

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005

Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015

The epidemiology of pancreatitis and pancreatic cancer.
Dhiraj Yadav, Albert B Lowenfels. Gastroenterology 2013

Prospective risk of cancer in CDKN2A germline mutation carriers.
A M Goldstein, J P Struewing, M C Fraser, M W Smith, M A Tucker. J Med Genet 2004

High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions.
Aimee L Lucas, Reena Shakya, Marla D Lipsyc, Elana B Mitchel, Sheila Kumar, Caroline Hwang, Liyong Deng, Catherine Devoe, John A Chabot, Matthias Szabolcs,[...]. Clin Cancer Res 2013

Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution.
Michelle Chan-Seng-Yue, Jaeseung C Kim, Gavin W Wilson, Karen Ng, Eugenia Flores Figueroa, Grainne M O'Kane, Ashton A Connor, Robert E Denroche, Robert C Grant, Jessica McLeod,[...]. Nat Genet 2020

Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
G Lal, G Liu, B Schmocker, P Kaurah, H Ozcelik, S A Narod, M Redston, S Gallinger. Cancer Res 2000

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018

Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Johann de Bono, Joaquin Mateo, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Oliver Sartor, Neeraj Agarwal, David Olmos,[...]. N Engl J Med 2020

Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
Marcia Irene Canto, Michael Goggins, Charles J Yeo, Constance Griffin, Jennifer E Axilbund, Kieran Brune, Syed Z Ali, Sanjay Jagannath, Gloria M Petersen, Elliot K Fishman,[...]. Clin Gastroenterol Hepatol 2004

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.
Jenna Lilyquist, Holly LaDuca, Eric Polley, Brigette Tippin Davis, Hermela Shimelis, Chunling Hu, Steven N Hart, Jill S Dolinsky, Fergus J Couch, David E Goldgar. Gynecol Oncol 2017

Inherited DNA-Repair Defects in Colorectal Cancer.
Saud H AlDubayan, Marios Giannakis, Nathanael D Moore, G Celine Han, Brendan Reardon, Tsuyoshi Hamada, Xinmeng Jasmine Mu, Reiko Nishihara, Zhirong Qian, Li Liu,[...]. Am J Hum Genet 2018

Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.
C M Phelan, J Iqbal, H T Lynch, J Lubinski, J Gronwald, P Moller, P Ghadirian, W D Foulkes, S Armel, A Eisen,[...]. Br J Cancer 2014

Cancer risks and mortality in heterozygous ATM mutation carriers.
Deborah Thompson, Silvia Duedal, Jennifer Kirner, Lesley McGuffog, James Last, Anne Reiman, Philip Byrd, Malcolm Taylor, Douglas F Easton. J Natl Cancer Inst 2005

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016

Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.
Harvey A Risch, John R McLaughlin, David E C Cole, Barry Rosen, Linda Bradley, Isabel Fan, James Tang, Song Li, Shiyu Zhang, Patricia A Shaw,[...]. J Natl Cancer Inst 2006

Altered exocrine function can drive adipose wasting in early pancreatic cancer.
Laura V Danai, Ana Babic, Michael H Rosenthal, Emily A Dennstedt, Alexander Muir, Evan C Lien, Jared R Mayers, Karen Tai, Allison N Lau, Paul Jones-Sali,[...]. Nature 2018

Phases of Metabolic and Soft Tissue Changes in Months Preceding a Diagnosis of Pancreatic Ductal Adenocarcinoma.
Raghuwansh P Sah, Ayush Sharma, Sajan Nagpal, Sri Harsha Patlolla, Anil Sharma, Harika Kandlakunta, Vincent Anani, Ramcharan Singh Angom, Amrit K Kamboj, Nazir Ahmed,[...]. Gastroenterology 2019

Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.
Jared R Mayers, Chen Wu, Clary B Clish, Peter Kraft, Margaret E Torrence, Brian P Fiske, Chen Yuan, Ying Bao, Mary K Townsend, Shelley S Tworoger,[...]. Nat Med 2014

BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high-risk pancreatic cancer screening and pancreatic cancer cohorts.
Aimee L Lucas, Laura E Frado, Caroline Hwang, Sheila Kumar, Lauren G Khanna, Elana J Levinson, John A Chabot, Wendy K Chung, Harold Frucht. Cancer 2014

Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
Linda C Chu, Seyoun Park, Satomi Kawamoto, Daniel F Fouladi, Shahab Shayesteh, Eva S Zinreich, Jefferson S Graves, Karen M Horton, Ralph H Hruban, Alan L Yuille,[...]. AJR Am J Roentgenol 2019

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015

Association between homologous recombination repair gene mutations and response to oxaliplatin in pancreatic cancer.
Tomohiro Kondo, Masashi Kanai, Tadayuki Kou, Tomohiro Sakuma, Hiroaki Mochizuki, Mayumi Kamada, Masahiko Nakatsui, Norimitsu Uza, Yuzo Kodama, Toshihiko Masui,[...]. Oncotarget 2018

Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.
Michael J Pishvaian, Robert J Bender, David Halverson, Lola Rahib, Andrew E Hendifar, Sameh Mikhail, Vincent Chung, Vincent J Picozzi, Davendra Sohal, Edik M Blais,[...]. Clin Cancer Res 2018

Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers.
Conan G Kinsey, Soledad A Camolotto, Amelie M Boespflug, Katrin P Guillen, Mona Foth, Amanda Truong, Sophia S Schuman, Jill E Shea, Michael T Seipp, Jeffrey T Yap,[...]. Nat Med 2019

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011

Pancreatic cancer screening in high-risk individuals with germline genetic mutations.
Tomas DaVee, Emmanuel Coronel, Charilaos Papafragkakis, Sayam Thaiudom, Gandhi Lanke, Raja C Chakinala, Graciela M Nogueras González, Manoop S Bhutani, William A Ross, Brian R Weston,[...]. Gastrointest Endosc 2018

Anticipation in familial pancreatic cancer.
C D McFaul, W Greenhalf, J Earl, N Howes, J P Neoptolemos, R Kress, M Sina-Frey, H Rieder, S Hahn, D K Bartsch. Gut 2006

Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families.
Femke A de Snoo, D Timothy Bishop, Wilma Bergman, Inge van Leeuwen, Clasine van der Drift, Frans A van Nieuwpoort, Coby J Out-Luiting, Hans F Vasen, Jeanet A C ter Huurne, Rune R Frants,[...]. Clin Cancer Res 2008

Geographical variation in the penetrance of CDKN2A mutations for melanoma.
D Timothy Bishop, Florence Demenais, Alisa M Goldstein, Wilma Bergman, Julia Newton Bishop, Brigitte Bressac-de Paillerets, Agnès Chompret, Paola Ghiorzo, Nelleke Gruis, Johan Hansson,[...]. J Natl Cancer Inst 2002

Hypermutation In Pancreatic Cancer.
Jeremy L Humphris, Ann-Marie Patch, Katia Nones, Peter J Bailey, Amber L Johns, Skye McKay, David K Chang, David K Miller, Marina Pajic, Karin S Kassahn,[...]. Gastroenterology 2017

Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series.
Vinciane Rebours, Marie-Christine Boutron-Ruault, Matthieu Schnee, Claude Férec, Frédérique Maire, Pascal Hammel, Philippe Ruszniewski, Philippe Lévy. Am J Gastroenterol 2008

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015

Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis.
F M Giardiello, G J Offerhaus, D H Lee, A J Krush, A C Tersmette, S V Booker, N C Kelley, S R Hamilton. Gut 1993

Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group.
A B Lowenfels, P Maisonneuve, G Cavallini, R W Ammann, P G Lankisch, J R Andersen, E P Dimagno, A Andrén-Sandberg, L Domellöf. N Engl J Med 1993

High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations.
M G F van Lier, A Wagner, E M H Mathus-Vliegen, E J Kuipers, E W Steyerberg, M E van Leerdam. Am J Gastroenterol 2010

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.
Ilir Agalliu, Robert Gern, Suzanne Leanza, Robert D Burk. Clin Cancer Res 2009

CDKN2A Germline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations.
Robert R McWilliams, Eric D Wieben, Kari G Chaffee, Samuel O Antwi, Leon Raskin, Olufunmilayo I Olopade, Donghui Li, W Edward Highsmith, Gerardo Colon-Otero, Lauren G Khanna,[...]. Cancer Epidemiol Biomarkers Prev 2018

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.
Nadine Tung, Nancy U Lin, John Kidd, Brian A Allen, Nanda Singh, Richard J Wenstrup, Anne-Renee Hartman, Eric P Winer, Judy E Garber. J Clin Oncol 2016

A multimodality test to guide the management of patients with a pancreatic cyst.
Simeon Springer, David L Masica, Marco Dal Molin, Christopher Douville, Christopher J Thoburn, Bahman Afsari, Lu Li, Joshua D Cohen, Elizabeth Thompson, Peter J Allen,[...]. Sci Transl Med 2019

Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
Aatur D Singhi, Kevin McGrath, Randall E Brand, Asif Khalid, Herbert J Zeh, Jennifer S Chennat, Kenneth E Fasanella, Georgios I Papachristou, Adam Slivka, David L Bartlett,[...]. Gut 2018

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.